Evidence map›Paper›PMID 36286313›Full record

ReviewJournal of cardiovascular development and disease2022

Inadvertent Lead Malposition in the Left Heart during Implantation of Cardiac Electric Devices: A Systematic Review.

Lorenzo Spighi, Francesco Notaristefano, Silvia Piraccini, Giuseppe Giuffrè, Alberto Barengo, Matteo D'Ammando, Salvatore Notaristefano, Giuseppe Bagliani, Gianluca Zingarini, Fabio Angeli and 2 more

Abstract readReview
In one paragraph

Review in Journal of cardiovascular development and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A right wire in the wrong place.Internal and emergency medicine · 2024
    Article
  8. Novel Device Therapies for Heart Failure.Journal of cardiovascular development and disease · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lorenzo SpighiStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Francesco NotaristefanoStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.ORCID 0000-0003-0904-6577
Silvia PiracciniStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Giuseppe GiuffrèStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Alberto BarengoStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Matteo D'AmmandoStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Salvatore NotaristefanoStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Giuseppe BaglianiStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Gianluca ZingariniStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Fabio AngeliDepartment of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.ORCID 0000-0003-4925-7985
Paolo VerdecchiaStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.
Claudio CavalliniStruttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe inadvertent lead malposition in the left heart (ILMLH) is an under-recognized event, which may complicate the implantation of cardiac electronic devices (CIEDs).

methodsWe investigated the clinical conditions associated with ILMLH and the treatment strategies in these patients. We made a systematic review of the literature and identified 132 studies which reported 157 patients with ILMLH.

resultsThe mean age of patients was 68 years, and 83 were women. ILMLH was diagnosed, on average, 365 days after CIEDs implantation. Coexisting conditions were patent foramen ovale in 29% of patients, arterial puncture in 24%, perforation of the interatrial septum in 20%, atrial septal defect in 16% and perforation of the interventricular septum in 4%. At the time of diagnosis of ILMLH, 46% of patients were asymptomatic, 31% had acute TIA or stroke and 15% had overt heart failure. Overall, 14% of patients were receiving anticoagulants at the time of diagnosis of ILMLH. After diagnosis of ILMLH, percutaneous or surgical lead extraction was carried out in 93 patients (59%), whereas 43 (27%) received anticoagulation. During a mean 9-month follow-up after diagnosis of ILMLH, four patients experienced TIA or stroke (three on oral anticoagulant therapy and one after percutaneous lead extraction).

conclusionILMLH is a rare complication, which is usually diagnosed about one year after implantation of CIEDs. An early diagnosis of ILMLH is important. Lead extraction is a safe and effective alternative to anticoagulants.

Indexed as

anticoagulationcardiac implantable electric devicesimplantable cardioverter defibrillatorlead extractionlead malpositionpacemakerstroketransient ischemic attack

Identifiers

PMID36286313
PMCPMC9604651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.